Many potentially efficient drugs have been created to treat neurological disorders, but they cannot be used in practice.
Typically, for a condition such as epilepsy, it is essential to act at exactly the right time and place in the brain. For this reason, the team of researchers led by Christophe Bernard at Inserm Unit 1106, “Institute of Systems Neuroscience” (INS), with the help of scientists at the École des Mines de Saint-Étienne and Linköping University (Sweden) have developed an organic electronic micropump which, when combined with an anticonvulsant drug, enables localised inhibition of epileptic seizure in brain tissue in vitro. This research is published in the journal Advanced Materials.
Drugs constitute the most widely used approach for treating brain disorders. However, many promising drugs failed during clinical testing for several reasons:
- they are diluted in potentially toxic solutions,
- they may themselves be toxic when they reach organs to which they were not initially directed,
- the blood-brain barrier, which separates the brain from the blood circulation, prevents most drugs from reaching their targets in the brain,
- drugs that succeed in penetrating the brain will act in a non-specific manner, i.e. on healthy regions of the brain, altering their functions.
Epilepsy is a typical example of a condition for which many drugs could not be commercialised because of their harmful effects, when they might have been effective for treating patients resistant to conventional treatments .
During an epileptic seizure, the nerve cells in a specific area of the brain are suddenly activated in an excessive manner. How can this phenomenon be controlled without affecting healthy brain regions? To answer this question, Christophe Bernard’s team, in collaboration with a team led by George Malliaras at the Georges Charpak-Provence Campus of the École des Mines of Saint-Étienne and Swedish scientists led by Magnus Berggren from Linköping University, have developed a biocompatible micropump that makes it possible to deliver therapeutic substances directly to the relevant areas of the brain.
The micropump (20 times thinner than a hair) is composed of a membrane known as “cation exchange,” i.e., it has negative ions attached to its surface. It thus attracts small positively charged molecules, whether these are ions or drugs. When an electrical current is applied to it, the flow of electrons generated projects the molecules of interest toward the target area.
The Latest on: Drug delivery system
via Google News
The Latest on: Drug delivery system
- The recent progress in investigating the inhibitory impact of nanosponges and antiviral delivery against SARS-CoV-2on August 1, 2022 at 7:25 am
Furthermore, intravenous-injected drugs based on nanosponge systems can also be effective in multivalent ... effects for improved biological neutralization as well as antiviral drug delivery. The ...
- Pharmaceutical Excipients Market Players Focus on Development of Next-gen Drug Delivery Systems, States TMR Studyon August 1, 2022 at 4:30 am
The global pharmaceutical excipients market is estimated to register growth at a CAGR of 5% during the forecast period 2019 - 2027, ...
- $1.7 Billion Worldwide Pharmaceutical Drug Delivery Industry to 2027 - Featuring GSK, Johnson & Johnson, Novartis and Pfizer Among Otherson July 29, 2022 at 1:33 am
The "Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering. The global ...
- Here’s what some drug delivery devices look like on a CT scanon July 28, 2022 at 1:09 pm
If you've ever wondered what the inside of some impressive drug delivery technology innovations looks like, look no further.
- Liposomal Drug Delivery Devices Global Market to Reach $6.03 Billion by 2026on July 28, 2022 at 11:45 am
The "Liposomal Drug Delivery Devices Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
- Pharmaceutical Drug Delivery Market Revenue to Cross $2296.17 Bn, Globally by 2027 at 6.6% CAGR | Exclusive Report by The Insight Partnerson July 26, 2022 at 7:30 am
The Insight Partners published latest research study on "Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Route of ...
- Becoming an Expert: Studying how long-acting drug delivery formulations interact with the human immune systemon July 25, 2022 at 11:57 pm
Danielle Brain is a fourth year PhD student and Research Associate in the Immunocompatibility Group, associated with the Centre of Excellence for Long-acting Therapeutics (CELT). Her PhD is funded by ...
- Global Pharmaceutical Drug Delivery Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecastson July 25, 2022 at 12:15 pm
Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.
- Pharmaceutical Drug Delivery Market 2022 Growth by Opportunities, Application, Current Trend, and Forecast by 2030on July 24, 2022 at 10:51 pm
Based on Patient Care Setting, the global Pharmaceutical Drug Delivery market is segmented in Diagnostic Centers, Hospitals, Ambulatory Surgery Centers, Home Care Settings, Other Facilities of Use, ...
- 6 drug delivery innovations you need to knowon July 21, 2022 at 2:04 pm
From wearable insulin delivery devices to drug-eluting implants and everything in between, drug delivery innovation never stops.
via Bing News